Related Experiment Video
Updated: Aug 20, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Phosphorylation and hypoxia-induced heme oxygenase-1 gene expression in cardiomyocytes
Guimei Wu1, José Marín-García, Terry B Rogers
1The Molecular Cardiology and Neuromuscular Institute, 75 Raritan Avenue, Highland Park, NJ 08904, USA.
Insights
Hypoxia increases heme oxygenase-1 (HO-1) expression in cardiomyocytes via protein kinase activation and phosphatase-1 (PP-1) downregulation. Nuclear factors NF-kB and AP-1 are involved in this stress response.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Cellular Stress Response
Background:
- Heme oxygenase-1 (HO-1) is a key stress protein regulating heme degradation.
- Cardiomyocytes respond to hypoxic stress through complex molecular pathways.
- The role of protein phosphorylation and dephosphorylation in HO-1 regulation under hypoxia was investigated.
Purpose of the Study:
- To investigate the role of protein kinases and phosphatases in modulating HO-1 expression in cardiomyocytes during hypoxia.
- To elucidate the signaling pathways involved in hypoxia-induced HO-1 gene expression.
Main Methods:
- Neonatal rat cardiomyocytes were exposed to hypoxic conditions.
- HO-1 expression was assessed using Northern blot, Western blot, and transfection assays.
- Kinase and phosphatase inhibitors (staurosporine, SB202190, okadaic acid) and antisense vectors were employed.
Main Results:
- Hypoxia significantly induced HO-1 expression in cardiomyocytes.
- Kinase inhibitors blocked hypoxia-induced HO-1 expression, while phosphatase inhibition (OA, antisense PP-1) induced it.
- Nuclear factors NF-kB and AP-1 were identified as key players in the HO-1 promoter activation under hypoxia.
Conclusions:
- Protein kinase activation and reduced phosphatase-1 (PP-1) activity contribute to hypoxia-induced HO-1 gene expression in cardiomyocytes.
- The HO-1 promoter region, including NF-kB and AP-1 binding sites, is crucial for transcriptional activation during hypoxic stress.
Background:
Heme oxygenase-1 (HO-1) is a stress protein and the rate-limiting enzyme in heme degradation. We sought to examine the notion that protein kinases and phosphatases through phosphorylation and dephosphorylation modulate the HO-1 expression in cardiomyocytes under hypoxic conditions.
Methods And Results:
Exposure of neonatal rat cardiomyocytes to hypoxia markedly induced the HO-1 expression, as assessed by Northern blot, Western blot, and transfection assay. The hypoxia-induced HO-1 expression was blocked by the kinase inhibitors staurosporine and SB202190 in a dose-dependent manner. Hypoxia decreased the activity of phosphatase-1 (PP-1). To examine the effect of PP-1 inhibition on HO-1 expression we used the phosphatase inhibitor okadaic acid (OA) and an antisense vector. OA treatment or overexpression of the antisense PP-1 transcript markedly induced HO-1 expression. Furthermore, transfection assay using HO-1 promoter constructs revealed the involvement of the nuclear factor kB (NF-kB) and Activator protein-1 (AP-1) in the hypoxia-induced activation of the HO-1 gene. The HO-1 promoter activity was modulated by OA under normoxic conditions or staurosporine under hypoxia.
Conclusions:
Our results suggest that activation of protein kinases and downregulation of PP-1 activity contribute to the hypoxia-induced HO-1 gene expression and that the proximal HO-1 promoter region containing NF-kB and AP-1 binding sites is likely to play a role in the transcriptional activation of the HO-1 gene in cardiomyocytes in response to hypoxic stress.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Cell Specific Gene Expression
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cellular Adaptation II: Hypertrophy
